MediMix aims to bring high value medical information to Belgian healthcare professionals via multiple channels. Our team covers congresses and symposia all over the world. In collaboration with Belgian and international experts, we bring the newest data in several different formats to Belgian physicians.
Latest publications
Prof Dr Erik van Cutsem presented results from two pivotal studies at the recent ASCO annual meeting, both examining the role of lifestyle factors—specifically physical activity and diet—in patients with
Prof Dr Luis Paz-Ares summarises his presentation from the session ‘New drugs in oncology: incorporation into practice’. He starts with a comprehensive overview of recent advances in the treatment of
At ASCO 2025, Dr Laure-Anne Teuwen and Prof Dr François Duhoux discussed the exploratory biomarker results from the DESTINY-Breast06 study.
At ASCO 2025, Prof Dr Karim Vermaelen discussed the interim analysis of the Phase 3 trial exploring tarlatamab, a bispecific T-cell engager, in patients with extensive-stage small cell lung cancer
At ASCO 2025, Prof Dr Christophe Dooms interviewed Dr Kristof Cuppens about the SACHI trial, a Phase 3 randomised controlled trial investigating the combination of savolitinib and osimertinib in EGFR-mutant